Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis

Most multiple sclerosis (MS) patients given currently available disease-modifying drugs (DMDs) experience progressive disability. Accordingly, there is a need for new treatments that can limit the generation of new waves T cell autoreactivity that drive disease progression. Notably, immune cells exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jide, Song, Min, Kaufman, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940650/
https://www.ncbi.nlm.nih.gov/pubmed/33686135
http://dx.doi.org/10.1038/s41598-021-84751-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940650/
https://www.ncbi.nlm.nih.gov/pubmed/33686135
http://dx.doi.org/10.1038/s41598-021-84751-3

Ejemplares similares